Navigation Links
Sangamo BioSciences Reports Second Quarter 2008 Financial Results
Date:7/23/2008

the treatment of critical limb ischemia. The data from this trial demonstrated that administration of the ZFP transcription factor resulted in a statistically significant increase in circulating stem cells in the peripheral blood. In addition, within a subgroup in which bone marrow cells were examined before and after treatment, the data suggests that subjects who showed the most marked clinical improvements, as judged by limb salvage, ulcer healing, reduction in pain and increased oxygen concentrations in the tissues of the lower limbs, also showed the greatest increase in bone marrow stem cells. This observation of stem cell mobilization after treatment with Sangamo's ZFP TF activator of VEGF-A, is being further investigated in an ongoing Phase 2 trial of SB-509, SB-509-703.

-- Announcement of research and license agreement with F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. (Roche) for the use of ZFP technology to develop transgenic animals. In July, Sangamo and Sigma-Aldrich Corporation jointly announced a research and license agreement to provide Roche with non-exclusive, worldwide rights for the use of Sangamo's ZFP nuclease (ZFN(TM)) technology to develop cell-lines and transgenic animals with targeted modifications in a specified gene in a specified species. Roche also has an option for an exclusive, worldwide license from Sangamo for the commercial use of such ZFN-generated transgenic animals in the production of therapeutic and diagnostic products.

-- Publication of preclinical data in Nature Biotechnology. Papers highlighting therapeutic and research applications of Sangamo's ZFN technology were published in the scientific journal, Nature Biotechnology. The first paper demonstrated the use of ZFNs to efficiently generate transgenic animals, in this case zebrafish, a widely recognized system for human disease modeling and in vivo drug discovery. A second publication described the successful ZFN-mediated disruption of the CCR5 gene in hu
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Sangamo BioSciences Announces Second Quarter Conference Call and Webcast
2. Sangamo BioSciences and Sigma-Aldrich Announce Research and License Agreement With Roche for the Use of ZFN Technology for Generation of Transgenic Animals
3. Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants
4. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration
5. Sangamo BioSciences to Present at the Canaccord Adams Diabetes and Obesity Conference
6. Sangamo BioSciences Announces Presentation of Phase 1 Data of ZFP Therapeutic at International Society for Cellular Therapy (ISCT) Meeting
7. Sangamo BioSciences Nominates Thomas G. Wiggans to Its Board of Directors
8. Sangamo BioSciences Announces First Quarter Conference Call and Webcast
9. Sangamo BioSciences Announces License Agreement For the Use of ZFP Technology For Generation of Transgenic Animals
10. Sangamo BioSciences to Present at the Cowen and Company 28th Annual Health Care Conference
11. Sangamo BioSciences Announces Expansion of Research and License Agreement With Genentech for ZFP Technology for Protein Pharmaceutical Production
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)NEW YORK, Dec. 2 Nearly 600 medical research executives, scientists, policy makers, and funders today convened to explore novel development approaches and innovative funding strategies at the inaugur
(Date:12/2/2009)LELYSTAD, The Netherlands, December 2 Pepscan Holding NV,the Netherlands based biotechnology company focusing on protein mimicking,technology for the generation of immune therapeutics today announced
(Date:12/2/2009)NANJING, China, Dec. 2 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group,("Simcere" or the "Company") (NYSE: SCR ), a leading pharmaceutical company,specializing in the development, manufacturing, a
(Date:12/1/2009)Dr. Kerry Solomon announced that he has joined Carolina Eyecare Physicians and has launched his redesigned website at www.DrKerrySolomon.com , which was developed by Medical Consulting Group. Dr. So
Breaking Biology Technology:Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Dutch Biotech Company Pepscan Appoints New CEO 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6
...ONG, Sept. 7 /Xinhua-PRNewswire-FirstCall/ -- Chin...: CTDC; "CTDC" or the "Company") today,announced t...olar energy,sector. With strong government commitm...able energy in the coming decades and rising energ...trategy will deliver shareholder,value and higher ...
...f=Astoria Hotel New York City 5:30-7:30 p.m. (ET),...), a medical device company focused on developing ...nts for the spine, announced today,that it will ho...rs and,analysts at the Waldorf=Astoria Hotel in Ne...30 p.m. to 7:30 p.m. ET. The reception will be ho...
...LLE, Md., Sept. 7 Human Genome,Sciences, Inc. (Na...n at the,Bear Stearns 20th Annual Healthcare Confe...sed at http://www.hgsi.com (Logo: http://www.n...ber of Human Genome Sciences, senior management te...day, September 11, 2007 at 4:00 pm,Eastern Time. ...
Other Biology Technology:China Technology Announces Entry to the Solar Energy Sector 2China Technology Announces Entry to the Solar Energy Sector 3NuVasive to Host Investor Reception on September 11, 2007 2NuVasive to Host Investor Reception on September 11, 2007 3NuVasive to Host Investor Reception on September 11, 2007 4
(Date:12/3/2009)A coating on windows or solar panels that repels grime and dirt? Expanded battery storage capacities for the next electric car? New Tel Aviv University research, just published in Nature Nanotechnolo
(Date:12/3/2009)ALBUQUERQUE, N.M. Most scientists believe that staph infections are caused by many bacterial cells that signal each other to emit toxins. The signaling process is called quorum sensing because many b
(Date:12/3/2009)Have you ever felt overly upset by a social snubbing? Your genetics, not your friends, may be at fault. , Scientists have long known that opium-like painkillers, called opioids, relieve not only phys
Breaking Biology News(10 mins):A window that washes itself? 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3Endoscopy within 24 hours shows better outcomes in elderly with peptic ulcer bleeding 54683 1Endoscopy within 24 hours shows better outcomes in elderly with peptic ulcer bleeding 54683 2Endoscopy within 24 hours shows better outcomes in elderly with peptic ulcer bleeding 54683 3Endoscopy within 24 hours shows better outcomes in elderly with peptic ulcer bleeding 54683 4Special Stem Cells Build Biological Bypass 54680 1Special Stem Cells Build Biological Bypass 54680 2Breckenridge Pharmaceutical Enters Agreement with Orit Laboratories 28West Caldwell NJ 29 to Market Ergocalciferol 28Vitamin D 29 Capsules 54676 1Breckenridge Pharmaceutical Enters Agreement with Orit Laboratories 28West Caldwell NJ 29 to Market Ergocalciferol 28Vitamin D 29 Capsules 54676 2
...epends share an attribute with paper airplanes: Un...researchers have been puzzled by how the long, lin... in a cell are folded into the shapes they must as...wn that for many of the most complex and essential...idden in the inner cavity of a type of molecule ca...
...t there are more bee species than previously thoug...in over a hundred years, John S. Ascher, a researc...y at the American Museum of Natural History, compi... more than 19,200 described bee species, showcasin...is new species inventory documents 2,000 more desc...
...es, a healthy immune system, protection against so... yet another item for the expanding list of vitami...eeps the heart, the body,s long-distance runner, f...harmacologist Robert U. Simpson, Ph.D., thinks it,... , In studies in rats, Simpson and his team repor...
Other Biology News:Researchers reveal insights into hidden world of protein folding 2Researchers reveal insights into hidden world of protein folding 3Researchers reveal insights into hidden world of protein folding 4Bee species outnumber mammals and birds combined 2Vitamin D: New way to treat heart failure? 2Vitamin D: New way to treat heart failure? 3
Mouse Anti-Human Serpin A3 Monoclonal Antibody, Unconjugated, Clone 213907 from R&D Systems
Sheep Growth Hormone from Cell Sciences
Goat Anti-Human SorCS1 Polyclonal Antibody, Unconjugated from R&D Systems
Goat Anti-Viral CCI Polyclonal Antibody, Biotin Conjugated from R&D Systems
Biology Products: